1
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Mammalian MDM2 binding proteins and uses thereof. Philadelphia Health and Education Corporation, Licata & Tyrrell P C, January 23, 2007: US07166712 (2 worldwide citation)

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...


2
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Isolated antibody specific for a mammalian MDM2 binding protein comprising SEQ ID No. 2 or 4. Philadelphia Health and Education Corporation, Licata & Tyrrell P C, June 8, 2010: US07732577

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...


3
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Mammalian MDM2 binding proteins. Philadelphia Health and Education Corporation, Licata & Tyrrell P C, December 4, 2007: US07304142

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...


4
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Mammalian MDM2 binding proteins and uses thereof. Licata & Tyrrell PC, June 7, 2007: US20070129324-A1

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...


5
Mark Thomas Boyd, Nikolina Vlatkovic, Mark Brady: Cancer Treatment. University of Liverpool, DAVIS WRIGHT TREMAINE Los Angeles, April 10, 2008: US20080085279-A1

The present invention relates to the inhibitors of MDM2 Binding Protein (MTBP) activity that may be used as medicaments. Such medicaments may be used to prevent or treat cancers. A preferred inhibitor is an siRNA molecule that is specific for silencing MTBP expression. The invention further relates ...


6
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Mammalian MDM2 Binding Proteins and Uses Thereof. Licata & Tyrrell PC, January 15, 2009: US20090017538-A1

Isolated nucleic acid sequences encoding mammalian binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In a ...


7
Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic: Mammalian mdm2 binding proteins and uses thereof. Licatla & Tyrrell PC, December 15, 2005: US20050277764-A1

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...


8
Mark Thomas Boyd, Dale Stewart Hainee, Nikolina Vlatkovle: Mammalian MDM2 Binding Proteins and Uses Thereof. Licata & Tyrrell PC, November 11, 2010: US20100286362-A1

Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. ...



Click the thumbnails below to visualize the patent trend.